VEC.L: Summary for VECTURA GROUP PLC ORD 0.025P - Yahoo Finance

UK Markets close in 1 hr 32 mins

Vectura Group plc (VEC.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
144.50+2.20 (+1.55%)
As of 2:39PM GMT. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous close142.30
Bid144.50 x 382500
Ask144.60 x 252100
Day's range140.35 - 145.70
52-week range122.90 - 183.70
Avg. volume1,543,368
Market cap979.67M
PE ratio (TTM)-6,568.18
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • days ago

    Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

    Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)?

  • GlobeNewswire5 days ago

    Vectura Group plc: Pre-close update

    Significant business development progress with year-end revenues in line with expectations. Chippenham, UK- 11 January 2017: Vectura Group plc, an industry-leading device and formulation business for inhaled ...

  • Vectura Group Plc – Value Analysis (LONDON:VEC) : January 9, 2017
    Capital Cube7 days ago

    Vectura Group Plc – Value Analysis (LONDON:VEC) : January 9, 2017

    Categories: Europe Value Analsysis Yahoo Finance Click here to see latest analysis Capitalcube gives Vectura Group Plc a score of 50. Our analysis is based on comparing Vectura Group Plc with the following peers – ReNeuron Group plc, Hikma Pharmaceuticals Plc, Dechra Pharmaceuticals PLC, AstraZeneca PLC, GlaxoSmithKline plc, BTG plc, Sinclair Pharma plc and ECO Animal Health Group plc (RENE-GB, HIK-GB, ... Read more (Read more...)